Full text is available at the source.
Abstract
The black market for two unapproved GLP-1 weight loss drugs is growing rapidly.
- The demand for these drugs may stem from their perceived effectiveness in weight loss.
- Unregulated access to these medications could pose significant health risks to users.
- The absence of oversight may result in variations in drug quality and safety.
- Potential side effects and long-term consequences of using these unapproved drugs remain unclear.
Simplified